PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25760532-3	2015	Among the 41 compounds tested, trimethylamine, methimazole, itopride, and tozasertib (50 muM) suppressed benzydamine N-oxygenation at a substrate concentration of 50 muM by approximately 50% after co-incubation.	Methimazole	47-58	latexin	Homo sapiens	89-92	
28243269-5	2016	The oxidation peak current at the new potential (0.4 V vs. SCE) was linearly dependent on the concentration of methimazole in the range of 7.0 - 130 muM with a detection limit of 3.7 muM (S/N = 3).	Methimazole	111-122	latexin	Homo sapiens	149-152	
28243269-5	2016	The oxidation peak current at the new potential (0.4 V vs. SCE) was linearly dependent on the concentration of methimazole in the range of 7.0 - 130 muM with a detection limit of 3.7 muM (S/N = 3).	Methimazole	111-122	latexin	Homo sapiens	183-186	
25760532-3	2015	Among the 41 compounds tested, trimethylamine, methimazole, itopride, and tozasertib (50 muM) suppressed benzydamine N-oxygenation at a substrate concentration of 50 muM by approximately 50% after co-incubation.	Methimazole	47-58	latexin	Homo sapiens	166-169	
25760532-5	2015	Apparent competitive inhibition by methimazole (0-50 muM) of sulindac sulfide S-oxygenation was observed with FMO3 proteins.	Methimazole	35-46	latexin	Homo sapiens	53-56